Published in
Springer Verlag, PharmacoEconomics, 4(31), p. 317-333
DOI: 10.1007/s40273-013-0031-z
Links
Tools
The cost effectiveness of pharmacological treatments for generalized anxiety disorder.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
Generalized anxiety disorder (GAD) is one of the most prevalent anxiety disorders, with important implications for patients and healthcare resources. However, few economic evaluations of pharmacological treatments for GAD have been published to date, and those available have assessed only a limited number of drugs.